Breaking News Instant updates and real-time market news.

MRK

Merck

$61.67

0.42 (0.69%)

12:50
01/23/18
01/23
12:50
01/23/18
12:50

Call buyers in Merck as shares move higher

Call buyers in Merck as shares move higher. The stock up 44c to $61.69 and Mar 65s trade across the exchanges for 51 to 62c per contract. 18.7K trade on the day. Open interest is 14K and the contract captures earnings on 2/2.

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

MRK Merck
$61.67

0.42 (0.69%)

12/07/17
PIPR
12/07/17
NO CHANGE
PIPR
Roche lung cancer data underwhelming versus Merck's, says Piper Jaffray
Piper Jaffray analyst Richard Purkiss says that while Roche's (RHHBY) IMpower150 data are strong and suggesting a likelihood that the combination of Tecentriq with Avastin and chemo will be approved in non-small cell lung cancer, the data also appear underwhelming compared to Merck's (MRK) KN-21G trial data. The analyst does expect Tecentriq approval in lung cancer next year and reiterates an Overweight rating on Roche. Whether KN-021G represents the "high water mark" for efficacy can only be answered following full presentation of the remaining pivotal Phase 3 trials in this setting, and until then confusion is likely to remain, Purkiss tells investors in a research note. Merck in premarket trading is up 85c to $55.20 while Roche is down 93c to $30.40.
01/16/18
RHCO
01/16/18
UPGRADE
RHCO
Buy
Merck upgraded to Buy from Hold at SunTrust
01/16/18
01/16/18
UPGRADE
Target $72

Buy
Merck upgraded on earlier than expected Keytruda trial success at SunTrust
As previously reported, SunTrust analyst John Boris upgraded Merck to Buy from Hold, stating that he had expected positive data from the Keynote-189 trial but that the positive results on Progression Free Survival and Overall Survival came earlier than expected. This timing should enable Merck to maintain its first-mover advantage in first-line non-squamous Non-Small Cell Lung Cancer, or NSCLC, in the U.S. and file in the EU, Boris tells investors. He raised his price target to $72 from $54 on Merck shares, which are up $4.09, or 7%, to $62.75 in morning trading.
01/17/18
BMOC
01/17/18
NO CHANGE
Target $72
BMOC
Outperform
Merck price target raised to $72 from $68 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Merck to $72 from $68, keeping his Outperform rating following a 6% move higher in the stock price yesterday. The analyst says he remains bullish based on a "meaningful upside for Keytruda" and better performance from supporting drug franchises such as Gardasil. Arfaei warns however that while Keytruda has solidified its lead in non-small cell lung cancer market, it remains the company's only major growth driver while immuno oncology becomes increasingly more competitive.

TODAY'S FREE FLY STORIES

08:25
06/19/18
06/19
08:25
06/19/18
08:25
General news
U.S. housing starts preview: »

U.S. housing starts…

ARGX

Argenx

$91.35

-1.03 (-1.12%)

08:25
06/19/18
06/19
08:25
06/19/18
08:25
Conference/Events
Argenx to hold a KOL breakfast symposium »

Management holds a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

TPH

TRI Pointe

$16.76

-0.205 (-1.21%)

08:24
06/19/18
06/19
08:24
06/19/18
08:24
Initiation
TRI Pointe initiated  »

TRI Pointe assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$37.78

-0.93 (-2.40%)

08:24
06/19/18
06/19
08:24
06/19/18
08:24
Initiation
Toll Brothers initiated  »

Toll Brothers assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$65.63

-0.36 (-0.55%)

08:23
06/19/18
06/19
08:23
06/19/18
08:23
Initiation
Owens Corning initiated  »

Owens Corning assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWHM

New Home Company

$10.00

-0.21 (-2.06%)

08:23
06/19/18
06/19
08:23
06/19/18
08:23
Initiation
New Home Company initiated  »

New Home Company assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$28.94

-0.11 (-0.38%)

08:22
06/19/18
06/19
08:22
06/19/18
08:22
Initiation
Jeld-Wen initiated  »

Jeld-Wen assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRBK

Green Brick

08:22
06/19/18
06/19
08:22
06/19/18
08:22
Initiation
Green Brick initiated  »

Green Brick assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

DPZ

Domino's Pizza

08:21
06/19/18
06/19
08:21
06/19/18
08:21
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 05

    Oct

DHI

D.R. Horton

$41.93

-0.91 (-2.12%)

08:21
06/19/18
06/19
08:21
06/19/18
08:21
Initiation
D.R. Horton initiated  »

D.R. Horton assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
06/19/18
06/19
08:21
06/19/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLH

William Lyon Homes

$24.10

-0.495 (-2.01%)

08:20
06/19/18
06/19
08:20
06/19/18
08:20
Initiation
William Lyon Homes initiated  »

William Lyon Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
06/19/18
06/19
08:20
06/19/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
06/19/18
06/19
08:20
06/19/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$199.72

-0.27 (-0.14%)

08:20
06/19/18
06/19
08:20
06/19/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
06/19/18
06/19
08:20
06/19/18
08:20
General news
U.S. equities were swept lower with global stocks »

U.S. equities were swept…

XLK

Technology Select Sector SPDR

$71.78

0.04 (0.06%)

08:19
06/19/18
06/19
08:19
06/19/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$74.94

0.83 (1.12%)

08:19
06/19/18
06/19
08:19
06/19/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$96.55

1.075 (1.13%)

08:19
06/19/18
06/19
08:19
06/19/18
08:19
Recommendations
Molina Healthcare analyst commentary  »

Molina Healthcare price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$111.91

-0.2 (-0.18%)

08:19
06/19/18
06/19
08:19
06/19/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$188.76

-0.11 (-0.06%)

08:19
06/19/18
06/19
08:19
06/19/18
08:19
Technical Analysis
Technical Take: Apple testing low of recent range in pre-market trading »

At the current price of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$59.60

-0.15 (-0.25%)

08:19
06/19/18
06/19
08:19
06/19/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$49.69

0.17 (0.34%)

08:18
06/19/18
06/19
08:18
06/19/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$50.78

-0.755 (-1.47%)

08:18
06/19/18
06/19
08:18
06/19/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$84.63

-0.85 (-0.99%)

08:18
06/19/18
06/19
08:18
06/19/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.